Pure Global

AMH Rapid Quantitative Test - India CDSCO Medical Device Registration

AMH Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_17f7b96ee8e089459c1b11fdab28d0ba_ed6182956032ea6776241a7f3a01cce2. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
AMH Rapid Quantitative Test
UID: IMP/IVD/2022/000035_17f7b96ee8e089459c1b11fdab28d0ba_ed6182956032ea6776241a7f3a01cce2

License Holder

DIYA SCIENTIFIC

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime AMH Rapid Quantitative Test is intended to quantify the concentration of AMH##PLACEHOLDER_0## in human serum or plasma on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of ovary function and fertility assessment. -Fluorescence immunoassay -Ovary function and fertility For in vitro diagnostic use only. For professional use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing